Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tarsus Pharmaceuticals (TARS) Tax Provisions: 2020-2022

Historic Tax Provisions for Tarsus Pharmaceuticals (TARS) over the last 3 years, with Dec 2022 value amounting to -$4,000.

  • Tarsus Pharmaceuticals' Tax Provisions rose 98.53% to -$5,000 in Q3 2022 from the same period last year, while for Sep 2022 it was -$291,000, marking a year-over-year decrease of 14650.00%. This contributed to the annual value of -$4,000 for FY2022, which is 107.27% down from last year.
  • According to the latest figures from FY2022, Tarsus Pharmaceuticals' Tax Provisions is -$4,000, which was down 107.27% from $55,000 recorded in FY2021.
  • In the past 5 years, Tarsus Pharmaceuticals' Tax Provisions registered a high of $55,000 during FY2021, and its lowest value of -$4,000 during FY2022.
  • For the 3-year period, Tarsus Pharmaceuticals' Tax Provisions averaged around $17,333, with its median value being $1,000 (2020).
  • In the last 5 years, Tarsus Pharmaceuticals' Tax Provisions soared by 5,400.00% in 2021 and then plummeted by 107.27% in 2022.
  • Tarsus Pharmaceuticals' Tax Provisions (Yearly) stood at $1,000 in 2020, then soared by 5,400.00% to $55,000 in 2021, then crashed by 107.27% to -$4,000 in 2022.